Top-News
Montag,
11.09.2017 19:50
von
PR Newswire
| Aufrufe: 147
Osmium Partners Issues Letter to Diversicare Board Urging a Substantial Increase in Dividends
Mann mit Smartphone und Tablet (Symbolbild).
© metamorworks / iStock / Getty Images Plus / Getty Images
PR Newswire
GREENBRAE, Calif., Sept. 11, 2017
GREENBRAE, Calif., Sept. 11, 2017 /PRNewswire/ -- Over the last several years, Diversicare (DVCR) has meaningfully increased revenue growth and funds from operations without success in increasing shareholder value. Osmium believes the current situation has created a wide spread between public market prices and what the business would be worth when valued from many angles. In our letter to the board of directors, we highlight our suggested strategy to close this gap and dramatically increase shareholder value from current prices.
- Osmium believes that fair value for Diversicare (NASDAQ: DVCR) shares is $17-25 per share vs. $9.40 market price.
- Since 2012, Diversicare has increased revenue from $200 million to nearly $600 million in 2017 while EBITDA has increased by a factor of 4.5x.
- Over the last three years, Diversicare has achieved 20% annualized revenue growth with 33% annualized EBITDA growth yet Diversicare's total annualized shareholder return is -3% and Diversicare's common stock trades at approximately 6x EV/2017 FFO (funds from operations) and just 0.29x EV/sales.
- Osmium issues 6 points of why Diversicare should increase its dividend from $0.22 to $1.00 per share (an incremental cost of $5 million per year). With a total of nearly $4.00 a share in 2017 in funds from operations, the company would still have sufficient liquidity to execute the continued growth strategy.
- Diversicare is in an unusual situation with a mix of strong growth metrics combined with a low valuation. The lack of analyst coverage and aggressive reinvestment into the core business, combined with low trading volumes that discourage investment currently explain why Diversicare trades at a deep discount.
Contact:
John H. Lewis
Managing Partner & CIO
Osmium Partners, LLC
jl@osmiumpartners.com
415.747.8698
View original content with multimedia:http://www.prnewswire.com/news-releases/osmium-partners-issues-letter-to-diversicare-board-urging-a-substantial-increase-in-dividends-300517187.html
SOURCE Osmium Partners, LLC
Werbung
Mehr Nachrichten zur Diversicare Healthcare Services Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
